liver storage of glycogen

BioWorld: Novel AAV-based gene therapy for liver glycogen storage disease type IX presented Liver glycogen storage disease type IX (GSD IX) accounts for 25% for all GSD cases, with a prevalence of 1 out of 100,000 patients. GSD IX is caused by deficiency in phosphorylase kinase (PhK), which ... Novel AAV-based gene therapy for liver glycogen storage disease type IX presented Glycogen storage disease type III (GSD III) is a rare genetic disorder resulting from mutations in the AGL gene, which encodes the glycogen debranching enzyme (GDE).

Understanding the Context

This enzyme is vital for the ... Glycogen storage diseases (GSDs) constitute a group of inherited metabolic disorders that impair normal glycogen synthesis or degradation, resulting in the accumulation of structurally abnormal ... EurekAlert!: Scientists discover key gene impacts liver energy storage, affecting metabolic disease risk Scientists discover key gene impacts liver energy storage, affecting metabolic disease risk Medical Xpress: Key gene found to control liver's choice between sugar and fat storage Key gene found to control liver's choice between sugar and fat storage FierceBiotech: Ultragenyx plans push for first gene therapy in glycogen storage disease after phase 3 success Ultragenyx is gearing up to take its glycogen storage disease (GSD) treatment to regulators next year after the gene therapy helped patients reduce their intake of cornstarch, which is currently used ... Ultragenyx plans push for first gene therapy in glycogen storage disease after phase 3 success